Rigshosp, Dept Vasc Surg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.;Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark..
Karolinska Hosp, Dept Vasc Surg, Stockholm, Sweden..
Karolinska Hosp, Dept Vasc Surg, Stockholm, Sweden..
Sahlgrens Univ Hosp, Dept Hybrid & Intervent Surg, Unit Vasc Surg, Gothenburg, Sweden..
Kalmar Hosp, Dept Surg, Kalmar, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Vascular Surgery.
Skane Univ Hosp, Vasc Ctr, Malmö, Sweden..
Linköping Univ, Dept Thorac & Vasc Surg, Linköping, Sweden.;Linköping Univ, Dept Med & Hlth Sci, Linköping, Sweden..
Örebro Univ Hosp, Fac Med & Vasc Surg, Dept Cardiothorac & Vasc Surg, Örebro, Sweden..
Örebro Univ Hosp, Fac Med & Vasc Surg, Dept Cardiothorac & Vasc Surg, Örebro, Sweden..
Umeå Univ Hosp, Dept Surg & Perioperat Sci, Surg, Umeå, Sweden..
Cent Hosp Karlstad, Dept Surg, Karlstad, Sweden..
Falun Cent Hosp, Dept Surg, Falun, Sweden..
Helsingborg Hosp, Dept Surg, Helsingborg, Sweden..
Jönköping Hosp, Dept Surg, Jönköping, Sweden..
Sunderby Hosp, Dept Surg, Sunderbyn, Sweden..
Umeå Univ Hosp, Dept Surg & Perioperat Sci, Surg, Umeå, Sweden..
NU Hospitalgrp, Dept Surg, Trollhättan Uddevalla, Sweden..
Östersunds Hosp, Dept Surg, Östersund, Sweden..
Gävle Cent Hosp, Dept Surg, Gävle, Sweden..
Karolinska Hosp, Dept Vasc Surg, Stockholm, Sweden..
Västerås Hosp, Dept Vasc Surg, Västerås, Sweden..
Hudiksvall Hosp, Dept Surg, Hudiksvall, Sweden..
Borås Hosp, Dept Surg, Borås, Sweden..
Skaraborg Hosp, Dept Vasc Surg, Skoevde, Sweden..
Kristianstad Hosp, Dept Surg, Kristianstad, Sweden..
Reg Hosp Sundsvall, Dept Surg, Sundsvall, Sweden..
Malar Hosp, Dept Surg, Eskilstuna, Sweden..
Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.;Soder Sjukhuset, Unit Vasc Surg, Dept Surg, Stockholm, Sweden..
Objective: The aim was to describe the microbiology of surgically treated infective native (mycotic) aortic aneurysms (INAAs), and associated survival and development of infection-related complications (IRCs). Methods: Data were pooled from 2 nationwide studies on surgically treated patients with INAAs in Sweden, between 1994 - 2016. Patients were grouped and analyzed according to culture results: 1) Staphylococcus aureus, 2) Streptococcus species (sp.), 3) Salmonella sp., 4) Enterococcus sp., 5) Gram-negative intestinal bacteria, 6) Other sp. (all other species found in culture), and 7) Negative cultures. Results: A sum of 182 patients were included, mean age 71 years (standard deviation; SD: 8.9). The median follow-up was 50.3 months (range 0 - 360). 128 (70.3%) patients had positive blood and/or tissue culture; Staphylococcus aureus n = 38 (20.9%), Streptococcus sp. n = 37 (20.3%), Salmonella sp. n = 19 (10.4%), Enterococcus sp. n = 16 (8.8%), Gram-negative intestinal bacteria n = 6, (3.3%), Other sp. n = 12 (6.6%) and Negative cultures n = 54 (29.7%). The estimated survival for the largest groups at 2-years after surgery was: Staphylococcus aureus 62% (95% Confidence interval 53.9 - 70.1), Streptococcus sp. 74.7% (67.4 - 82.0), Salmonella sp. 73.7% (63.6 - 83.8), Enterococcus sp. 61.9% (49.6 - 74.2), and Negative cultures 89.8% (85.5 - 94.1), P =.051. There were 37 IRCs (20.3%), and 19 (51.4%) were fatal, the frequency was insignificant between the groups. The majority of IRCs, 30/37 (81%), developed during the first postoperative year. Conclusion: In this assessment of microbiological findings of INAAs in Sweden, 50% of the pathogens were Staphylococcus aureus, Streptococcus sp., or Salmonella sp.. The overall 20%-frequency of IRCs, and its association with high mortality, motivates long-term antibiotic treatment regardless of microbial findings.
Elsevier BV Elsevier, 2022. Vol. 78, p. 112-122